Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Treatment of gastric cancer Orditura M; Galizia G; Sforza V; Gambardella V; Fabozzi A; Laterza MM; Andreozzi F; Ventriglia J; Savastano B; Mabilia A; Lieto E; Ciardiello F; De Vita FWorld J Gastroenterol 2014[Feb]; 20 (7): 1635-49The authors focused on the current surgical treatment of resectable gastric cancer, and significance of peri- and post-operative chemo or chemoradiation. Gastric cancer is the 4(th) most commonly diagnosed cancer and the second leading cause of cancer death worldwide. Surgery remains the only curative therapy, while perioperative and adjuvant chemotherapy, as well as chemoradiation, can improve outcome of resectable gastric cancer with extended lymph node dissection. More than half of radically resected gastric cancer patients relapse locally or with distant metastases, or receive the diagnosis of gastric cancer when tumor is disseminated; therefore, median survival rarely exceeds 12 mo, and 5-years survival is less than 10%. Cisplatin and fluoropyrimidine-based chemotherapy, with addition of trastuzumab in human epidermal growth factor receptor 2 positive patients, is the widely used treatment in stage IV patients fit for chemotherapy. Recent evidence supports the use of second-line chemotherapy after progression in patients with good performance status.|Antibodies, Monoclonal, Humanized/administration & dosage[MESH]|Antineoplastic Combined Chemotherapy Protocols/therapeutic use[MESH]|Chemoradiotherapy/methods[MESH]|Chemotherapy, Adjuvant/methods[MESH]|Cisplatin/administration & dosage[MESH]|Clinical Trials as Topic[MESH]|Fluorouracil/administration & dosage[MESH]|Humans[MESH]|Neoplasm Metastasis[MESH]|Palliative Care/methods[MESH]|Radiotherapy/methods[MESH]|Receptor, ErbB-2/metabolism[MESH]|Stomach Neoplasms/*drug therapy/*radiotherapy/*surgery[MESH]|Trastuzumab[MESH] |
